本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Candel Therapeutics, Inc.

8.75
+0.810010.20%
盤後8.750.00000.00%19:59 EDT
成交量:102.23萬
成交額:870.49萬
市值:4.13億
市盈率:-5.03
高:8.79
開:7.96
低:7.96
收:7.94
資料載入中...

公司資料

公司名字:
Candel Therapeutics, Inc.
交易所:
NASDAQ
成立時間:
2003
員工人數:
42
公司地址:
117 Kendrick Street,Suite 450,Needham,Massachusetts,United States
郵編:
02494
電話:
傳真:
- -
簡介:
Candel Therapeutics, Inc.於2003年6月在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司,專註於開發可引發個體化、全身性抗腫瘤免疫反應的現成病毒免疫療法,以幫助患者對抗癌症。

董事

名稱
職位
Paul Peter Tak
Director,President and Chief Executive Officer
Paul B. Manning
Director,chairman of the board
Chris Martell
Director
Diem Nguyen
Director
Edward J. Benz, Jr.
Director
Estuardo Aguilar Cordova
Director
Gary J. Nabel
Director
Joseph C. Papa
Director
Renee Gaeta
Director

股東

名稱
職位
Paul Peter Tak
Director,President and Chief Executive Officer
Jason A. Amello
Chief Financial Officer, Treasurer and Secretary
Francesca Barone
Chief Scientific Officer
Seshu Tyagarajan
Chief Technical and Development Officer
W. Garrett Nichols
Chief Medical Officer